Trump to Link Tylenol Use in Pregnancy to Autism Risks

WASHINGTON, D.C. — Former President Donald Trump is expected to announce a controversial link between the use of Tylenol by pregnant women and autism risk during a press event on Monday. This announcement comes despite existing medical guidelines that deem the over-the-counter medication safe for pregnant women.

Trump’s health officials plan to discuss findings that suggest acetaminophen, the active ingredient in Tylenol, may be associated with increased risks for autism spectrum disorder (ASD). This condition includes challenges with communication and repetitive behaviors. The report, published by The Washington Post, cites four anonymous sources familiar with the announcement.

In early September, The Wall Street Journal revealed that Trump’s health secretary was preparing to declare a potential link between Tylenol use in pregnancy and autism. However, medical authorities continue to endorse the safety of the drug based on current guidelines.

Additionally, the upcoming announcement may introduce a proposal to investigate leucovorin, a medication that some trials suggest could treat autism symptoms. Certain studies have shown early signs indicating improvements in speech and social understanding among children treated with leucovorin.

Meanwhile, Trump hinted at the importance of the impending announcement, stating, “I think it’s gonna be a very important announcement. I think it’s gonna be one of the most important things that we will do.” The event comes as discussions on autism and related treatments gain heightened attention.

Reuters contributed to this report.